Atena Institute for Clinical Research

What Atena Institute for Clinical Research does

Atena Institute for Clinical Research (legal name: Instituto Atena de Pesquisa Clínica; CNPJ 39.580.637/0001-30) is a private, non-profit clinical research site founded in 1998 in Natal, Rio Grande do Norte, Brazil. The institute executes Phase II-IV clinical trial protocols on a contract basis for pharmaceutical and biotech sponsors, with a therapeutic portfolio spanning cardiology, infectious diseases (including COVID-19 vaccines and treatments), rare diseases, orthopedics, and other specialties. It maintains a volunteer database of 5,000+ individuals concentrated in Rio Grande do Norte and Ceará, accepting participants from across Northeast Brazil, and operates three sites: a Natal headquarters, and partner/branch clinics in Mossoró (Clínica Humane-LEMECC) and Fortaleza (Integrare Medicina Clínica).

The institute's core operating stack consists of an internal volunteer database for protocol matching, digital tools for remote patient monitoring, full biological sample logistics, and a Permanent Council overseeing quality management, clinical best practices, and patient safety. Infrastructure includes modern equipment acquired with Bill & Melinda Gates Foundation support for COVID-19 vaccine protocols, an ISO 27001-certified cloud data environment, and facility approval from the Chinese NMPA regulator. A hospital referral network (Memorial, Santa Cruz, HOS Promater, Natal Star, IOMR) supports adverse-event escalation. The core team is 40 professionals, demonstrated to scale to 150+ during the pandemic, with leadership holding Harvard, USP, and IHI credentials.

Revenue is generated through multi-year contracts with pharmaceutical and biotech sponsors who pay for protocol execution; volunteer participation is uncompensated. The institute reports a 99 NPS among trial participants, reflecting its volunteer-centric operational culture. Marketing and recruitment channels span digital media (Instagram, LinkedIn, WhatsApp, Google Business Profile), a blog and "Atena em foco" newsletter, and conventional media (radio, TV, newspapers) to reach diverse populations across Northeast Brazil.

Name

Atena Institute for Clinical Research

Legal name

Instituto Atena de Pesquisa Clínica

Website

https://atena.institute

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

11–50 employees

Short description

Atena Institute for Clinical Research is a non-profit Brazilian clinical research site founded in 1998 in Natal, Rio Grande do Norte, executing Phase II-IV drug and vaccine trials for pharmaceutical and biotech sponsors across cardiology, infectious diseases, and rare diseases, with sites in Natal, Mossoró, and Fortaleza.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Professional, Scientific, and Technical Services (54)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Site Data Management Support (EDC/Source/SDV Readiness) (HLAGACAL)

akta.pro secondary industry

Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN)

Keywords

• Clinical research services
• Clinical trial execution
• Contract research organization
• Volunteer recruitment
• Vaccine clinical trials

Headquarters

HQ city

Natal

HQ country

Brazil

HQ region

Latin America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Clinical Trial Services (Contract Research): Instituto Atena is contracted by pharmaceutical and biotech companies (sponsors) to conduct clinical trial protocols. Revenue is earned by executing the full trial lifecycle: volunteer recruitment, product administration, logistics, and patient follow-up. The institute has conducted trials across cardiology, infectious disease (including COVID-19 vaccines), rare diseases, orthopedics, hypertension, and other therapeutic areas.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Instituto Atena is a clinical research institute that contracts with pharmaceutical and biotech sponsors to execute Phase II-IV clinical trial protocols end-to-end. Its services encompass volunteer recruitment, administration of investigational products, biological sample and data logistics, and ongoing patient monitoring across cardiology, infectious diseases, rare diseases, orthopedics, and other therapeutic areas. The institute operates a volunteer database, ISO 27001-certified data infrastructure, and a high-standard research facility in Natal supported by the Bill & Melinda Gates Foundation.

Product overview

The Instituto Atena is a single, unified clinical research institute founded in 1998 that provides end-to-end clinical research services rather than a software product platform. Its core offering comprises volunteer recruitment (via its database, digital media, and conventional channels), study product administration, biological sample and data logistics, and volunteer medical follow-up — all structured through a multi-phase validation process from laboratory testing to population-level validation. The institute conducts clinical trials across cardiology, infectious diseases (including COVID-19 vaccines and treatments), rare diseases, orthopedics, and other specialties, supported by its high-standard facilities in Natal/RN, Mossoró/RN, and Fortaleza/CE. The Bill & Melinda Gates Foundation supported the acquisition of equipment for COVID-19 vaccine protocols.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Research Services End-to-end clinical research services for pharmaceutical and biotech sponsors covering Phase II-IV protocols, including volunteer recruitment, study product administration, biological sample logistics, and patient follow-up across cardiology, infectious diseases, rare diseases, orthopedics, and other specialties.
• COVID-19 Vaccine and Treatment Trials Clinical trials for COVID-19 vaccines and treatments conducted with high safety standards, supported by the Bill & Melinda Gates Foundation, covering moderate to critical disease cases.
• Volunteer Recruitment Services

Quantifiable outcome

• 5,000+ volunteers enrolled across all protocols
• +3 more outcomes

Named customers17 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Eleven partnerships are on record, tiered core and minor.

• Chinese Regulatory Agency (NMPA)coreOthersThe institute's clinical research facility was inspected and approved by the Chinese regulatory agency (NMPA — National Medical Products Administration), confirming the facility meets international quality standards required for conducting clinical trials.
• Hospital MemorialcoreStrategic or Co-development PartnerHospital partnership for clinical trial support — provides hospital referral and adverse event escalation for trial participants requiring advanced medical care.
• Hospital Santa Cruz / zabZabminorStrategic or Co-development PartnerListed as a partner hospital for clinical trial support and adverse event escalation.
• IOMRminorStrategic or Co-development PartnerListed as a partner organization for clinical research collaboration.
• HOS PromaterminorStrategic or Co-development PartnerListed as a partner hospital for clinical trial support.
• Natal StarminorStrategic or Co-development PartnerListed as a partner organization in the institute's partner network.
• Integrare Medicina ClínicacoreChannel Partner/ Reseller/ DistributorPartner clinic in Fortaleza/CE acting as a branch clinical trial site. Serves as an additional recruitment and execution point for institute protocols.
• Clínica Humane (LEMECC)coreChannel Partner/ Reseller/ DistributorPartner clinic in Mossoró/RN operating as LEMECC (Liga Mossoroense de Estudo e Combate ao Câncer). Acts as a branch clinical trial site for the institute.
• FleuryminorStrategic or Co-development PartnerListed as a partner company providing diagnostic laboratory services supporting clinical trial operations.
• PhilipsminorStrategic or Co-development PartnerListed as a technology partner potentially providing medical equipment for clinical research operations.
• NutrividaminorStrategic or Co-development PartnerListed as a partner company in the institute's support network.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Syneos Health: Clinical and commercial solutions CRO with global site management and biopharmaceutical services; competes for the same pharma-sponsored clinical trial execution work, particularly in cardiology and infectious disease.
• ICON plc: Global CRO offering Phase I-IV clinical trial services with a significant Brazilian and Latin American presence; competes for sponsor protocol execution contracts at multinational scale.
• Medpace: Mid-to-large CRO focused on Phase II-IV clinical trials across multiple therapeutic areas including cardiology; competes for sponsor protocols but with a global full-service delivery model.
• IQVIA: Global CRO and clinical research services leader with established LATAM operations; competes for the same pharmaceutical sponsor contracts as Atena, but at vastly larger scale and with multi-region execution capabilities.
• Charles River Laboratories: Global CRO and preclinical/clinical services provider with broad Phase I-IV capabilities; competes for sponsor contracts at multinational scale and offers a wider portfolio of research services.
• Parexel International: Global CRO providing Phase I-IV clinical trial management and site activation services with established Latin American footprint; competes for similar pharma-sponsored protocol contracts as Atena.

Direct peers

• Worldwide Clinical Trials: Mid-sized global CRO focused on complex Phase II-IV trials in cardiology, infectious disease, and rare diseases — closely overlapping Atena's therapeutic area mix and serving similar sponsor base.

Regional players

• Hospital Israelita Albert Einstein: Brazilian academic medical center with a dedicated clinical research institute running pharma-sponsored Phase I-IV trials; competes for the same Brazilian pharma sponsor contracts and volunteer pool.
• Hospital de Clínicas de Porto Alegre: Brazilian academic medical center running a large portfolio of sponsored clinical trials across multiple therapeutic areas; comparable to Atena as a clinical trial execution site in Brazil.

Emerging players

• Eurofarma Laboratórios: Brazilian pharmaceutical company with significant in-house clinical research operations and CRO services; an emerging regional player in clinical trial execution with overlapping LATAM sponsor relationships.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Instagraminstagram.com/instituto.atena.oficial
• LinkedInlinkedin.com/company/institutoatena

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Atena Institute for Clinical Research